NCT03647904

Brief Summary

Description of Project: Multiple sclerosis (MS), a disorder of young and middle aged adults, is known to have a grave impact on one's well-being and incurs a significant cost to society due to the nearly 80% rate of unemployment. Over the past few decades, research has focused on increasing our understanding of the factors that lead to these high rates of unemployment in MS and ways to mitigate such factors. However, the majority of investigations examining the causes of unemployment in MS have been retrospective and limited their focus to factors such as demographics, disease severity and symptoms of MS (e.g., fatigue), and/ or work place features and accommodations. Few have examined the more intrinsic, or person-specific factors (e.g., personality, coping, health-related behaviors), which are also likely to significantly contribute to rates of unemployment in MS. In fact, these investigators have shown that personality characteristics, anxiety, depression, coping, and self-efficacy differ between individuals who are considering leaving the workforce and those staying employed; even in the presence of comparable demographics and disease variables. Based on these findings, and the knowledge that fatigue and cognition also greatly contribute to this decision, these investigators have proposed a comprehensive intervention that will target both the disease and person-specific factors in hope of assisting individuals with MS maintain their employment; the ultimate goal being to improve the overall quality of life and health of individuals with MS. The proposed modular intervention will be tailored to the individual based on a preliminary assessment and consist of cognitive rehabilitation, fatigue and symptom management, wellness intervention, psychological intervention, and occupational rehabilitation. Outcomes will be assessed following such intervention with the goal being either job maintenance or comparable life activities that will ensure continuity of purpose and satisfaction in life, health and health maintenance, and overall well-being.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 27, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

August 27, 2018

Status Verified

August 1, 2018

Enrollment Period

1 year

First QC Date

January 25, 2018

Last Update Submit

August 24, 2018

Conditions

Keywords

EmploymentSelf efficacy

Outcome Measures

Primary Outcomes (3)

  • Change in Work Commitment

    One's ability to maintain their current work status and function as measured by the employment outcome questionnaire

    baseline, immediate post-intervention, 3 month post-intervention

  • Change in adjustment to MS

    Self-reported perception of coping skills as measured by the COPE questionnaire

    baseline, immediate post-intervention, 3 month post-intervention

  • Change in self-efficacy

    Self-reported self-efficacy as measured by the General Self-efficacy Questionnaire

    baseline, immediate post-intervention, 3 month post-intervention

Secondary Outcomes (4)

  • Change in mood

    baseline, immediate post-intervention, 3 month post-intervention

  • Change in anxiety

    baseline, immediate post-intervention, 3 month post-intervention

  • Change in psychological well-being

    baseline, immediate post-intervention, 3 month post-intervention

  • Changes in stress

    baseline, immediate post-intervention, 3 month post-intervention

Study Arms (2)

SEMS Project

EXPERIMENTAL

A comprehensive modular intervention consisting of wellness, fatigue management, cognitive remediation and psychological treatment. Treatment will consist of a total of 12 weeks.

Behavioral: SEMS Project

Wait List Control

OTHER

Individuals in the wait list control arm will serve as controls for the first intervention group, but will receive the treatment following their three month assessment. The intervention following the waitlist control will be a comprehensive modular intervention consisting of wellness, fatigue management, cognitive remediation and psychological treatment. Treatment will consist of a total of 12 weeks.

Behavioral: SEMS Project

Interventions

SEMS ProjectBEHAVIORAL

TThe intervention is a culmination of five empirically supported interventions: (1) The MS Wellness Program aimed at developing lifestyle strategies to enhance quality of living and cope with various aspects of MS; (2) The FACETS intervention, which aims to reduce fatigue and improve self-efficacy; (3) The Modified Story Memory technique, which improves new learning and memory; (4) The Speed of Processing training, which improves performance on measures of processing speed in persons with MS. Finally, the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders, a cognitive behavioral intervention, which improves psychological functioning and functional outcomes.

SEMS ProjectWait List Control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with MS based on McDonald Criteria

You may not qualify if:

  • any neurological condition other than MS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kessler Foundation

East Hanover, New Jersey, 07936, United States

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Lauren Strober

    Kessler Foundation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes assessor will not know if individual were in the treatment group or waitlist control group
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Wait list control
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Scientist

Study Record Dates

First Submitted

January 25, 2018

First Posted

August 27, 2018

Study Start

October 1, 2017

Primary Completion

October 1, 2018

Study Completion

October 1, 2018

Last Updated

August 27, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations